Health ❯ Healthcare ❯ Regulations

FDA

Drug Approval Process Drug Safety Recalls Good Manufacturing Practices Drug Approval Processes Drug Compounding Drug Approval Drug Shortages HHS Clinical Trials Prohibited Treatments Product Recalls Botulinum Toxin Clinical Decision Support Software Wellness Devices Cell and Gene Therapies Stem Cell Therapy Vaccine Guidelines Policy Changes Recall Classifications Labeling Changes iPLEDGE REMS Medical Device Recalls Current Good Manufacturing Practices Compounded Medications Software as a Medical Device Drug Recalls Priority Review Vouchers Mammography Guidelines Mifepristone Peptide Injections Drug Enforcement Drug Approvals Drug Classifications General Wellness Products Wellness Products Compounding Pharmacies

Viatris Recalls One Lot of Xanax XR Nationwide After Tablets Fail FDA Dissolution Test

Failed dissolution tests raise concern about inconsistent dosing in the affected extended‑release tablets.

FDA Approves Vanda's Bysanti for Schizophrenia and Bipolar I in Adults

Honey Energy Supplement Recalled After FDA Finds Undeclared ED Drug

FDA Eases CMC Rules for Cell and Gene Therapies to Speed Development

FDA Eases Oversight of Wearables and Clinical Decision Support in Final Guidance

FDA Adds Boxed Liver Warning and Limits Elevidys to Ambulatory Boys 4 and Up

Moderna Trims 2025 Forecast as Q3 Loss Narrows and Revenue Beats

FDA Class II Recall Targets 580,000 Prazosin Bottles for Nitrosamine Overages

Louisiana Warns After Two Hospitalizations Tied to Unlicensed Botox Injections

FDA Sends Mass Warnings, Seeks to End 1997 Drug Ad Rule After White House Directive

Khloé Kardashian Shares Mexico Stem Cell Infusion Not Allowed in the U.S.

Tandem Diabetes Announces Urgent Medical Device Correction for t:slim X2 Pumps

FDA Ends GLP-1 Drug Shortages, Triggering New Pricing and Coverage Moves